IL92098A - Glucan dietary additives - Google Patents

Glucan dietary additives

Info

Publication number: IL92098A
Authority: IL; Israel
Prior art keywords: glucan; whole; dietary supplement; fiber; glucans
Prior art date: 1988-10-28

Application number

IL9209889A

Other languages

English (en)

Other versions

IL92098A0 (en

Original Assignee

Alpha Beta Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-28

Filing date

1989-10-23

Publication date

1994-04-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23004531&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL92098(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1989-10-23 Application filed by Alpha Beta Technology filed Critical Alpha Beta Technology

1990-07-12 Publication of IL92098A0 publication Critical patent/IL92098A0/xx

1994-04-12 Publication of IL92098A publication Critical patent/IL92098A/en

Links

229920001503 Glucan Polymers 0.000 title claims description 170
239000002778 food additive Substances 0.000 title abstract description 10
239000000835 fiber Substances 0.000 claims abstract description 53
235000005911 diet Nutrition 0.000 claims abstract description 29
239000000203 mixture Substances 0.000 claims abstract description 21
241001465754 Metazoa Species 0.000 claims abstract description 15
235000021391 short chain fatty acids Nutrition 0.000 claims abstract description 13
150000004666 short chain fatty acids Chemical class 0.000 claims abstract description 13
239000004067 bulking agent Substances 0.000 claims abstract description 12
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 46
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 36
230000037213 diet Effects 0.000 claims description 27
102000004190 Enzymes Human genes 0.000 claims description 19
108090000790 Enzymes Proteins 0.000 claims description 19
235000015872 dietary supplement Nutrition 0.000 claims description 17
230000029087 digestion Effects 0.000 claims description 17
210000005253 yeast cell Anatomy 0.000 claims description 16
102000005575 Cellulases Human genes 0.000 claims description 14
108010084185 Cellulases Proteins 0.000 claims description 14
230000002550 fecal effect Effects 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 5
230000002475 laxative effect Effects 0.000 claims description 3
230000004580 weight loss Effects 0.000 claims description 3
230000002708 enhancing effect Effects 0.000 claims description 2
239000008141 laxative Substances 0.000 claims description 2
239000012669 liquid formulation Substances 0.000 claims description 2
241000124008 Mammalia Species 0.000 claims 2
235000018823 dietary intake Nutrition 0.000 claims 2
244000025254 Cannabis sativa Species 0.000 claims 1
239000003292 glue Substances 0.000 claims 1
238000000034 method Methods 0.000 abstract description 24
229920002498 Beta-glucan Polymers 0.000 abstract description 3
230000000378 dietary effect Effects 0.000 abstract description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 46
235000013325 dietary fiber Nutrition 0.000 description 19
229940088598 enzyme Drugs 0.000 description 17
235000012000 cholesterol Nutrition 0.000 description 15
229940038580 oat bran Drugs 0.000 description 15
240000004808 Saccharomyces cerevisiae Species 0.000 description 13
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 13
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
210000004027 cell Anatomy 0.000 description 12
239000008103 glucose Substances 0.000 description 12
230000000694 effects Effects 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
108090000623 proteins and genes Proteins 0.000 description 11
229940088594 vitamin Drugs 0.000 description 11
229930003231 vitamin Natural products 0.000 description 11
235000013343 vitamin Nutrition 0.000 description 11
239000011782 vitamin Substances 0.000 description 11
241000699800 Cricetinae Species 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
229920002527 Glycogen Polymers 0.000 description 9
102000004895 Lipoproteins Human genes 0.000 description 9
108090001030 Lipoproteins Proteins 0.000 description 9
230000037396 body weight Effects 0.000 description 9
210000002421 cell wall Anatomy 0.000 description 9
235000013305 food Nutrition 0.000 description 9
229940096919 glycogen Drugs 0.000 description 9
230000003301 hydrolyzing effect Effects 0.000 description 9
230000008569 process Effects 0.000 description 9
230000006870 function Effects 0.000 description 8
235000016709 nutrition Nutrition 0.000 description 8
239000000047 product Substances 0.000 description 8
230000004584 weight gain Effects 0.000 description 8
235000019786 weight gain Nutrition 0.000 description 8
229920002101 Chitin Polymers 0.000 description 7
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 7
230000009467 reduction Effects 0.000 description 7
239000000243 solution Substances 0.000 description 7
235000015099 wheat brans Nutrition 0.000 description 7
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
210000001035 gastrointestinal tract Anatomy 0.000 description 6
229910052500 inorganic mineral Inorganic materials 0.000 description 6
239000000463 material Substances 0.000 description 6
239000011159 matrix material Substances 0.000 description 6
235000010755 mineral Nutrition 0.000 description 6
239000011707 mineral Substances 0.000 description 6
239000002245 particle Substances 0.000 description 6
239000000725 suspension Substances 0.000 description 6
238000008214 LDL Cholesterol Methods 0.000 description 5
108010007622 LDL Lipoproteins Proteins 0.000 description 5
102000007330 LDL Lipoproteins Human genes 0.000 description 5
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
235000020940 control diet Nutrition 0.000 description 5
239000012153 distilled water Substances 0.000 description 5
230000001965 increasing effect Effects 0.000 description 5
210000000936 intestine Anatomy 0.000 description 5
239000013589 supplement Substances 0.000 description 5
150000003626 triacylglycerols Chemical class 0.000 description 5
150000003722 vitamin derivatives Chemical class 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
229920002261 Corn starch Polymers 0.000 description 4
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
206010012735 Diarrhoea Diseases 0.000 description 4
241000282412 Homo Species 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
241000699673 Mesocricetus auratus Species 0.000 description 4
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
229930006000 Sucrose Natural products 0.000 description 4
230000009286 beneficial effect Effects 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
239000008120 corn starch Substances 0.000 description 4
RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
239000003925 fat Substances 0.000 description 4
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
238000009472 formulation Methods 0.000 description 4
150000004676 glycans Chemical class 0.000 description 4
235000009200 high fat diet Nutrition 0.000 description 4
230000003871 intestinal function Effects 0.000 description 4
235000021056 liquid food Nutrition 0.000 description 4
229920001282 polysaccharide Polymers 0.000 description 4
239000005017 polysaccharide Substances 0.000 description 4
229960002477 riboflavin Drugs 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
206010009944 Colon cancer Diseases 0.000 description 3
241000283984 Rodentia Species 0.000 description 3
-1 acetic acid Chemical class 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
235000013339 cereals Nutrition 0.000 description 3
208000019902 chronic diarrheal disease Diseases 0.000 description 3
230000000112 colonic effect Effects 0.000 description 3
208000029742 colonic neoplasm Diseases 0.000 description 3
239000002285 corn oil Substances 0.000 description 3
235000005687 corn oil Nutrition 0.000 description 3
230000018044 dehydration Effects 0.000 description 3
238000006297 dehydration reaction Methods 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
238000000605 extraction Methods 0.000 description 3
235000019197 fats Nutrition 0.000 description 3
238000000855 fermentation Methods 0.000 description 3
230000004151 fermentation Effects 0.000 description 3
239000012530 fluid Substances 0.000 description 3
230000036541 health Effects 0.000 description 3
230000000968 intestinal effect Effects 0.000 description 3
230000007794 irritation Effects 0.000 description 3
210000002429 large intestine Anatomy 0.000 description 3
239000007788 liquid Substances 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
230000035764 nutrition Effects 0.000 description 3
230000002572 peristaltic effect Effects 0.000 description 3
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000002151 riboflavin Substances 0.000 description 3
235000019192 riboflavin Nutrition 0.000 description 3
238000012360 testing method Methods 0.000 description 3
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 2
239000002028 Biomass Substances 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
235000019743 Choline chloride Nutrition 0.000 description 2
102100030797 Conserved oligomeric Golgi complex subunit 2 Human genes 0.000 description 2
108010023302 HDL Cholesterol Proteins 0.000 description 2
108010010234 HDL Lipoproteins Proteins 0.000 description 2
102000015779 HDL Lipoproteins Human genes 0.000 description 2
101000920113 Homo sapiens Conserved oligomeric Golgi complex subunit 2 Proteins 0.000 description 2
208000035150 Hypercholesterolemia Diseases 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
208000005016 Intestinal Neoplasms Diseases 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
241000209140 Triticum Species 0.000 description 2
235000021307 Triticum Nutrition 0.000 description 2
239000006096 absorbing agent Substances 0.000 description 2
229940022663 acetate Drugs 0.000 description 2
238000010306 acid treatment Methods 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
235000001465 calcium Nutrition 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229960005069 calcium Drugs 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
108010033929 calcium caseinate Proteins 0.000 description 2
229960002079 calcium pantothenate Drugs 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
229960003178 choline chloride Drugs 0.000 description 2
SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
239000003240 coconut oil Substances 0.000 description 2
235000019864 coconut oil Nutrition 0.000 description 2
210000001072 colon Anatomy 0.000 description 2
239000003086 colorant Substances 0.000 description 2
239000000356 contaminant Substances 0.000 description 2
ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
229910000366 copper(II) sulfate Inorganic materials 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
229960002104 cyanocobalamin Drugs 0.000 description 2
235000000639 cyanocobalamin Nutrition 0.000 description 2
239000011666 cyanocobalamin Substances 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
230000001079 digestive effect Effects 0.000 description 2
102000038379 digestive enzymes Human genes 0.000 description 2
108091007734 digestive enzymes Proteins 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
238000009826 distribution Methods 0.000 description 2
230000009144 enzymatic modification Effects 0.000 description 2
229960001781 ferrous sulfate Drugs 0.000 description 2
239000011790 ferrous sulphate Substances 0.000 description 2
235000003891 ferrous sulphate Nutrition 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
229960000304 folic acid Drugs 0.000 description 2
235000019152 folic acid Nutrition 0.000 description 2
239000011724 folic acid Substances 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
230000037406 food intake Effects 0.000 description 2
235000012631 food intake Nutrition 0.000 description 2
238000012239 gene modification Methods 0.000 description 2
230000005017 genetic modification Effects 0.000 description 2
235000013617 genetically modified food Nutrition 0.000 description 2
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
208000019622 heart disease Diseases 0.000 description 2
235000021192 high fiber diet Nutrition 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
201000002313 intestinal cancer Diseases 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
235000011147 magnesium chloride Nutrition 0.000 description 2
229940099596 manganese sulfate Drugs 0.000 description 2
239000011702 manganese sulphate Substances 0.000 description 2
235000007079 manganese sulphate Nutrition 0.000 description 2
SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
229960003966 nicotinamide Drugs 0.000 description 2
235000005152 nicotinamide Nutrition 0.000 description 2
239000011570 nicotinamide Substances 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
230000000737 periodic effect Effects 0.000 description 2
235000019175 phylloquinone Nutrition 0.000 description 2
239000011772 phylloquinone Substances 0.000 description 2
MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
229960001898 phytomenadione Drugs 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000001103 potassium chloride Substances 0.000 description 2
235000011164 potassium chloride Nutrition 0.000 description 2
229960002816 potassium chloride Drugs 0.000 description 2
239000001508 potassium citrate Substances 0.000 description 2
229960002635 potassium citrate Drugs 0.000 description 2
QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
235000011082 potassium citrates Nutrition 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
210000001938 protoplast Anatomy 0.000 description 2
238000000746 purification Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
229960001790 sodium citrate Drugs 0.000 description 2
229940071440 soy protein isolate Drugs 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
235000019157 thiamine Nutrition 0.000 description 2
229960003495 thiamine Drugs 0.000 description 2
239000011721 thiamine Substances 0.000 description 2
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
229960001763 zinc sulfate Drugs 0.000 description 2
229910000368 zinc sulfate Inorganic materials 0.000 description 2
BIIBYWQGRFWQKM-JVVROLKMSA-N (2S)-N-[4-(cyclopropylamino)-3,4-dioxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-[[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]amino]-4,4-dimethylpentanamide Chemical compound CC(C)(C)C[C@@H](C(NC(C[C@H](CCN1)C1=O)C(C(NC1CC1)=O)=O)=O)NC(/C=C/C(C=CC(Cl)=C1)=C1Cl)=O BIIBYWQGRFWQKM-JVVROLKMSA-N 0.000 description 1
AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 1
FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
DWKNOLCXIFYNFV-HSZRJFAPSA-N 2-[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]piperidin-4-yl]-5-oxopyrrolidine-2-carbonyl]amino]-n,n,6-trimethylpyridine-4-carboxamide Chemical compound CN(C)C(=O)C1=CC(C)=NC(NC(=O)[C@@H]2N(C(=O)CC2)C2CCN(CC=3C=C(C)C(Cl)=CC=3)CC2)=C1 DWKNOLCXIFYNFV-HSZRJFAPSA-N 0.000 description 1
UXHQLGLGLZKHTC-CUNXSJBXSA-N 4-[(3s,3ar)-3-cyclopentyl-7-(4-hydroxypiperidine-1-carbonyl)-3,3a,4,5-tetrahydropyrazolo[3,4-f]quinolin-2-yl]-2-chlorobenzonitrile Chemical compound C1CC(O)CCN1C(=O)C1=CC=C(C=2[C@@H]([C@H](C3CCCC3)N(N=2)C=2C=C(Cl)C(C#N)=CC=2)CC2)C2=N1 UXHQLGLGLZKHTC-CUNXSJBXSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
108010023063 Bacto-peptone Proteins 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
239000004380 Cholic acid Substances 0.000 description 1
244000060011 Cocos nucifera Species 0.000 description 1
235000013162 Cocos nucifera Nutrition 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical class CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
240000005979 Hordeum vulgare Species 0.000 description 1
235000007340 Hordeum vulgare Nutrition 0.000 description 1
108010028554 LDL Cholesterol Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
108010013563 Lipoprotein Lipase Proteins 0.000 description 1
102100022119 Lipoprotein lipase Human genes 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
241000235648 Pichia Species 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
241000700159 Rattus Species 0.000 description 1
VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
240000008331 Saccharomyces cerevisiae A364A Species 0.000 description 1
235000010954 Saccharomyces cerevisiae A364A Nutrition 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
229930003471 Vitamin B2 Natural products 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
229930003448 Vitamin K Natural products 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
238000000184 acid digestion Methods 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000037358 bacterial metabolism Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000023852 carbohydrate metabolic process Effects 0.000 description 1
235000021256 carbohydrate metabolism Nutrition 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001906 cholesterol absorption Effects 0.000 description 1
235000019416 cholic acid Nutrition 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
229960002471 cholic acid Drugs 0.000 description 1
229960001231 choline Drugs 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
206010009887 colitis Diseases 0.000 description 1
238000004040 coloring Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
235000005118 dietary health Nutrition 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
238000007824 enzymatic assay Methods 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
230000007071 enzymatic hydrolysis Effects 0.000 description 1
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
235000020774 essential nutrients Nutrition 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000012632 extractable Substances 0.000 description 1
230000004129 fatty acid metabolism Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000000446 fuel Substances 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
150000002402 hexoses Chemical class 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
235000021233 hypercaloric diet Nutrition 0.000 description 1
208000009326 ileitis Diseases 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
235000019626 lipase activity Nutrition 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
235000020888 liquid diet Nutrition 0.000 description 1
238000000464 low-speed centrifugation Methods 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000035772 mutation Effects 0.000 description 1
VOVZXURTCKPRDQ-CQSZACIVSA-N n-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=NC=C(C(=O)NC=2C=CC(OC(F)(F)Cl)=CC=2)C=C1C1=CC=NN1 VOVZXURTCKPRDQ-CQSZACIVSA-N 0.000 description 1
239000013642 negative control Substances 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
229940055726 pantothenic acid Drugs 0.000 description 1
235000019161 pantothenic acid Nutrition 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229960003975 potassium Drugs 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
239000011764 pyridoxine hydrochloride Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
229940108325 retinyl palmitate Drugs 0.000 description 1
235000019172 retinyl palmitate Nutrition 0.000 description 1
239000011769 retinyl palmitate Substances 0.000 description 1
235000021003 saturated fats Nutrition 0.000 description 1
238000001612 separation test Methods 0.000 description 1
239000002002 slurry Substances 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000008347 soybean phospholipid Substances 0.000 description 1
238000013222 sprague-dawley male rat Methods 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000003826 tablet Substances 0.000 description 1
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019164 vitamin B2 Nutrition 0.000 description 1
239000011716 vitamin B2 Substances 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
235000019168 vitamin K Nutrition 0.000 description 1
239000011712 vitamin K Substances 0.000 description 1
150000003721 vitamin K derivatives Chemical class 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
229940046010 vitamin k Drugs 0.000 description 1
KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/271—Curdlan; beta-1-3 glucan; Polysaccharides produced by agrobacterium or alcaligenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Jellies, Jams, And Syrups (AREA)

IL9209889A 1988-10-28 1989-10-23 Glucan dietary additives IL92098A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/264,091 US4962094A (en)	1988-10-28	1988-10-28	Glucan dietary additives

Publications (2)

Publication Number	Publication Date
IL92098A0 IL92098A0 (en)	1990-07-12
IL92098A true IL92098A (en)	1994-04-12

Family

ID=23004531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9209889A IL92098A (en)	1988-10-28	1989-10-23	Glucan dietary additives

Country Status (13)

Country	Link
US (1)	US4962094A (de)
EP (1)	EP0440725B1 (de)
JP (1)	JPH04505997A (de)
AT (1)	ATE106193T1 (de)
AU (1)	AU643670B2 (de)
CA (1)	CA2001754C (de)
DE (1)	DE68915773T2 (de)
IE (1)	IE64707B1 (de)
IL (1)	IL92098A (de)
MX (1)	MX168000B (de)
NZ (1)	NZ231176A (de)
WO (1)	WO1990004334A1 (de)
ZA (1)	ZA898174B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5370894A (en) *	1988-06-24	1994-12-06	The Nutrasweet Company	Carbohydrate cream substitute
US5153020A (en) *	1988-06-24	1992-10-06	The Nutrasweet Company	Carbohydrate cream substitute
US6020324A (en) *	1989-10-20	2000-02-01	The Collaborative Group, Ltd.	Glucan dietary additives
CA2036490A1 (en) *	1990-02-20	1991-08-21	Ruth G. Chiou	Method of preparing reduced fat foods
US5378491A (en) *	1990-02-20	1995-01-03	A. E. Staley Manufacturing Co.	Method of preparing a starch hydrolysate, an aqueous starch hydrolysate dispersion, method of preparing a food containing a starch hydrolysate, and a food formulation containing a starch hydrolysate
US5409726A (en) *	1990-02-20	1995-04-25	A. E. Staley Manufacturing Co.	Method of preparing reduced fat foods
US5372835A (en) *	1990-02-20	1994-12-13	A. E. Staley Manufacturing Company	Method of preparing reduced fat foods
US5374442A (en) *	1990-02-20	1994-12-20	A. E. Staley Manufacturing Company	Method of preparing reduced fat foods
US5368878A (en) *	1990-02-20	1994-11-29	A. E. Staley Manufacturing Company	Reduced fat meat products
US5387426A (en) *	1990-02-20	1995-02-07	A.E. Staley Manufacturing Company	Method of preparing reduced fat foods
US5436019A (en) *	1990-02-20	1995-07-25	A. E. Staley Manufacturing Co.	Method of preparing reduced fat foods
US5395640A (en) *	1990-02-20	1995-03-07	A.E. Staley Manufacturing Company	Method of preparing reduced fat foods
GB9022560D0 (en) *	1990-10-17	1990-11-28	G B Biotechnology Limited	Processing of waste
US5085875A (en) *	1990-10-15	1992-02-04	Alko Ltd.	Process of making a yeast fiber composition
AU651626B2 (en) *	1990-10-24	1994-07-28	Nestec S.A.	Medical foods having soluble fiber
US5545557A (en) *	1993-04-15	1996-08-13	Cpc International Inc.	Water insoluble coloring agent
US5376399A (en) *	1992-05-15	1994-12-27	A.E. Staley Manufacturing Co.	Reduced fat cremes
USH1394H (en) *	1992-05-22	1995-01-03	A. E. Staley Manufacturing Company	Method of preparing reduced fat spreads
USH1395H (en) *	1992-05-22	1995-01-03	A. E. Staley Manufacturing Company	Composition and method of preparing reduced fat spreads
DE4218768A1 (de) *	1992-06-06	1993-12-09	Basf Ag	Verfahren zur Herstellung von Cholinchlorid enthaltenden Pulvern, diese Pulver und ihre Verwendung
JP2766439B2 (ja) *	1992-10-26	1998-06-18	鐘紡株式会社	コレステロール抑制剤
EP0640348A1 (de) *	1993-07-26	1995-03-01	Akzo Nobel N.V.	Adjuvansmischung auf Ölbasis und auf Wasserbasis
HUT70567A (en) *	1993-08-06	1995-10-30	Cons Nutrition Lc	Animal feeds comprising yeast glucan and feed process for growth of animals based on feeds comprising yeast glucan
US5576015A (en) *	1995-03-02	1996-11-19	Donzis; Byron A.	Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
US5766668A (en) *	1995-03-27	1998-06-16	Chinook Group, Inc.	Method for synthesizing chloride based feed precursor and product resulting therefrom
US6214337B1 (en)	1995-04-18	2001-04-10	Biotec Asa	Animal feeds comprising yeast glucan
EP0756828B2 (de) *	1995-08-04	2010-09-22	N.V. Nutricia	Diätfasern enthaltende Nahrungszusammensetzung
AU720797B2 (en) *	1996-02-09	2000-06-15	Societe Des Produits Nestle S.A.	Nutrient composition for exercise
NL1006774C2 (nl) *	1996-08-14	1998-09-28	Univ Potchefstroom	Anti-atherosclerose- en anti-trombotisch middel en het gebruik daarvan.
AUPO430496A0 (en) *	1996-12-19	1997-01-23	Arnott's Biscuits Limited	Prebiotics and probiotics
US5786343A (en) *	1997-03-05	1998-07-28	Immudyne, Inc.	Phagocytosis activator compositions and their use
EP0875580A1 (de) *	1997-05-02	1998-11-04	Difass S.A.	Verfahren zur Herstellung von Polysacchariden aus Hefen
AUPO763197A0 (en) *	1997-06-30	1997-07-24	Sigma Pharmaceuticals Pty Ltd	Health supplement
WO1999065337A1 (en) *	1998-06-19	1999-12-23	Beth Israel Deaconess Medical Center	Dietary supplement for post-menopausal women
US6210686B1 (en)	1998-12-18	2001-04-03	Beth Israel Deaconess Medical Center	Dietary supplement and method for lowering risk of heart disease
US7238355B1 (en) *	1999-02-26	2007-07-03	Kirin Beer Kabushiki Kaisha	Coated material and process for producing the coated material
DE19911055A1 (de) *	1999-03-12	2000-09-21	Cognis Deutschland Gmbh	Verwendung von oberflächenaktiven Gemischen
JP2001055338A (ja) *	1999-08-13	2001-02-27	Kirin Brewery Co Ltd	酵母細胞壁画分からなる薬理用組成物
WO2001073104A1 (en) *	2000-03-24	2001-10-04	Societe Des Produits Nestle S.A.	Beta-glucans from filamentous fungi
CA2418030C (en) *	2000-08-03	2010-10-26	Martin Sauter	Isolation of glucan particles and uses thereof
EP1395246A1 (de) *	2001-05-23	2004-03-10	Institut National de la Recherche Scientifique	Biokompatible träger- oder hilfsstoffverbindungen für pharmazeutika oder lebensmittel und zum schutz
US6939864B1 (en) *	2001-07-09	2005-09-06	Purdue Research Foundation	Animal feed compositions and methods of using the same
NO20014256D0 (no)	2001-09-03	2001-09-03	Bjoern Kristiansen	Fremstilling av immunstimulerende forbindelse
KR20030087383A (ko) *	2002-05-08	2003-11-14	강상모	효모벽 추출물의 베타-글루칸을 이용한 건강증진 방법
US20070042930A1 (en) *	2002-08-13	2007-02-22	Ross Gordon D	Effect of beta-glucan on stem cell recruitment and tissue repair
DE10309281A1 (de) *	2003-03-04	2004-09-23	Satia Gmbh	Verfahren zur Herstellung eines beta-1,3-Glukans mit verbesserten Eigenschaften
US20050058671A1 (en) *	2003-05-09	2005-03-17	Bedding Peter M.J.	Dietary supplement and method for treating digestive system-related disorders
EP1663266B1 (de) *	2003-08-11	2013-02-20	Lesaffre et Compagnie	Hefezellwände zur behandlung oder vorbeugung der hyperglykämie und zur blutzuckerstabilisierung
US7514085B2 (en) *	2004-07-16	2009-04-07	Medimush A/S	Immune modulating compounds from fungi
CN101184780B (zh)	2005-05-05	2012-10-03	森馨香料公司	β-葡聚糖和甘露聚糖的制备
US20090005340A1 (en) *	2005-06-15	2009-01-01	Medimush A/S	Bioactive Agents Produced By Submerged Cultivation of a Basidiomycete Cell
WO2006133707A2 (en)	2005-06-15	2006-12-21	Medimush A/S	Anti-cancer combination treatment and kit-of-part
WO2007146440A2 (en) *	2006-06-15	2007-12-21	Biopolymer Engineering, Inc. Dba Biothera, Inc.	Glucan preparations
WO2008027581A1 (en) *	2006-09-01	2008-03-06	University Of Louisville	Mcrp antagonists and their uses
US20080167268A1 (en) *	2006-09-01	2008-07-10	Jun Yan	Particulate beta-glucan compositions for regulating dendritic cells
GB0622582D0 (en) *	2006-11-13	2006-12-20	Biotec Pharmacon Asa	Animal feeds and veterinary compositions
JP5238166B2 (ja) *	2007-02-02	2013-07-17	株式会社ヤクルト本社	インターロイキン１２産生抑制剤
EP1967078A1 (de) *	2007-03-08	2008-09-10	Probelte Pharma, S.A.	Verfahren und Vorrichtung zur Herstellung von Granatapfelextrakten
JP2007217435A (ja) *	2007-06-01	2007-08-30	Kirin Holdings Co Ltd	酵母細胞壁画分からなる便秘の予防及び／又は症状改善剤
TWI543713B (zh) *	2010-05-28	2016-08-01	美強生營養品美國控股公司	營養組成物類
US20110293783A1 (en) *	2010-05-28	2011-12-01	Anja Wittke	Nutritional compositions for enhancing immune function
US20110293784A1 (en) *	2010-05-28	2011-12-01	Anja Wittke	Milk-based nutritional compositions
TWI652992B (zh) *	2011-10-31	2019-03-11	興人生命科學股份有限公司	酵母來源之調味料、酵母蛋白質組成物之製造方法、及酵母來源之調味料之製造方法
CN103215194B (zh) *	2012-01-20	2015-05-27	蔡国珍	新型酵母菌及其应用
EP2948004A1 (de) *	2013-01-24	2015-12-02	Danstar Ferment AG	Hefezellwände mit vitamin d2, verwendungen davon und verfahren zur herstellung davon
WO2016007876A1 (en)	2014-07-10	2016-01-14	Biothera, Inc.	Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment
WO2016073763A2 (en)	2014-11-06	2016-05-12	Biothera, Inc.	Beta-glucan methods and compositions that affect the tumor microenvironment
GB201602410D0 (en) *	2016-02-10	2016-03-23	Tate & Lyle Ingredients	Methods for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates
TW201722281A (zh) *	2015-12-18	2017-07-01	Kohjin Life Sciences Co Ltd	保水劑及具有保水性的軟化劑與其製造方法
US10842809B2 (en)	2016-12-16	2020-11-24	Hills Pet Nutrition, Inc.	Pet food compositions
WO2018156888A1 (en)	2017-02-24	2018-08-30	Biothera Pharmaceuticals, Inc.	Beta glucan immunopharmacodynamics
WO2019170790A1 (en) *	2018-03-08	2019-09-12	Dsm Ip Assets B.V.	Yeast beta glucans
WO2020131069A1 (en) *	2018-12-20	2020-06-25	Hill's Pet Nutrition, Inc.	Pet food compositions
JP2019068843A (ja) *	2018-12-28	2019-05-09	ダンスター・フェルメント・アーゲー	ビタミンｄ２を含む酵母細胞壁、その使用、およびその産生方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1442108A1 (de) *	1961-02-23	1968-11-14	Kinki Yakult Seizo Kabushiki K	Verfahren zur Zersetzung der Zellwaende von Hefearten mittels ss-Glucanase,welche durch Mikroorganismen erzeugt wird
US3495990A (en) *	1967-03-02	1970-02-17	Pillsbury Co	Aerated food products
US3754925A (en) *	1970-03-24	1973-08-28	Takeda Chemical Industries Ltd	New thermo gelable polysaccharide containing foodstuffs
US3867554A (en) *	1972-11-29	1975-02-18	Robert William Sucher	Yeast glycan and process of making same
US4122196A (en) *	1974-11-18	1978-10-24	Anheuser-Busch, Incorporated	Process for the manufacture of yeast glycan
SE456911B (sv) *	1983-12-19	1988-11-14	Olle Larm	Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma
US4810646A (en) *	1984-11-28	1989-03-07	Massachusetts Institute Of Technology	Glucan compositions and process for preparation thereof
US4759942A (en) *	1985-09-19	1988-07-26	General Foods Corporation	Process for producing high fiber expanded cereals

1988
- 1988-10-28 US US07/264,091 patent/US4962094A/en not_active Expired - Lifetime
1989
- 1989-10-20 JP JP1511464A patent/JPH04505997A/ja active Pending
- 1989-10-20 EP EP89912342A patent/EP0440725B1/de not_active Expired - Lifetime
- 1989-10-20 AU AU44924/89A patent/AU643670B2/en not_active Expired
- 1989-10-20 AT AT89912342T patent/ATE106193T1/de not_active IP Right Cessation
- 1989-10-20 WO PCT/US1989/004734 patent/WO1990004334A1/en not_active Ceased
- 1989-10-20 DE DE68915773T patent/DE68915773T2/de not_active Expired - Lifetime
- 1989-10-23 IE IE341389A patent/IE64707B1/en not_active IP Right Cessation
- 1989-10-23 IL IL9209889A patent/IL92098A/en unknown
- 1989-10-27 NZ NZ231176A patent/NZ231176A/en unknown
- 1989-10-27 MX MX018129A patent/MX168000B/es unknown
- 1989-10-27 ZA ZA898174A patent/ZA898174B/xx unknown
- 1989-10-30 CA CA002001754A patent/CA2001754C/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU4492489A (en)	1990-05-14
DE68915773D1 (de)	1994-07-07
DE68915773T2 (de)	1994-11-03
NZ231176A (en)	1997-05-26
IL92098A0 (en)	1990-07-12
AU643670B2 (en)	1993-11-25
MX168000B (es)	1993-04-27
IE64707B1 (en)	1995-08-23
JPH04505997A (ja)	1992-10-22
ZA898174B (en)	1991-10-30
CA2001754C (en)	2000-08-22
ATE106193T1 (de)	1994-06-15
EP0440725A1 (de)	1991-08-14
US4962094A (en)	1990-10-09
IE893413L (en)	1990-04-28
EP0440725B1 (de)	1994-06-01
WO1990004334A1 (en)	1990-05-03
CA2001754A1 (en)	1990-04-28

Publication	Publication Date	Title
EP0440725B1 (de)	1994-06-01	Glukane als diaet Zusatzmittel
US6020324A (en)	2000-02-01	Glucan dietary additives
US6143731A (en)	2000-11-07	Glucan dietary additives
Butt et al.	2008	Oat: unique among the cereals
Srilakshmi	2006	Nutrition Science.
US8318213B2 (en)	2012-11-27	Plant extract mixtures and their uses
Anderson et al.	1994	Ten different dietary fibers have significantly different effects on serum and liver lipids of cholesterol-fed rats
Harmuth-Hoene et al.	1979	Effect of indigestible polysaccharides on protein digestibility and nitrogen retention in growing rats
DE60210604T2 (de)	2007-04-05	Polymer-kontrolliertes induziertes viskoses ballaststoffsystem und dessen verwendungen
US11013759B2 (en)	2021-05-25	Compositions for enhancing immune function in a pediatric subject
MXPA01012581A (es)	2002-04-10	Fraccion de gel sin fermentar de cascaras de semilla de psilio.
Rieckhoff et al.	1999	Effects of different cereal fibers on cholesterol and bile acid metabolism in the Syrian golden hamster
Afiati et al.	2019	The effectiveness β-glucan of shiitake mushrooms and Saccharomyces cerevisiae as antidiabetic and antioxidant in mice Sprague Dawley induced alloxan
Ullrich	1987	Evaluation of a high-fiber diet in hyperlipidemia: a review.
Han et al.	2003	Resistant starches of beans reduce the serum cholesterol concentration in rats
US4175124A (en)	1979-11-20	Method of treating hypercholesterolemia
TIETYEN et al.	1995	Hypocholesterolemic Potential of Oat Bran Treated with an Endo‐β‐D‐glucanase from Bacillus subfilis
Jun et al.	2012	Anti-obesity effects of chitosan and psyllium husk with L-ascorbic acid in guinea pigs
Pacheco Delahaye et al.	1998	Plant starches and oils. Their influence on digestion in rats
O'Brien et al.	1982	Cholesterolemic responses of rats to human-type diet ingredients
Zhang	2004	Evaluation of guar meal as a source of prebiotic galactomannans for laying hens
Kasper	2001	Effects of dietary fiber on vitamin metabolism
US20070243272A1 (en)	2007-10-18	Method for treating colon cancer with rice bran composition
KR20030091103A (ko)	2003-12-03	효소저항전분을 포함하는 면역활성 증강용 조성물
Cummings	2001	The Effect of Dietary Fiber on Fecal Weight and